259 related articles for article (PubMed ID: 30471415)
1. Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury.
Bader M; Li Y; Lecca D; Rubovitch V; Tweedie D; Glotfelty E; Rachmany L; Kim HK; Choi HI; Hoffer BJ; Pick CG; Greig NH; Kim DS
Neurobiol Dis; 2019 Apr; 124():439-453. PubMed ID: 30471415
[TBL] [Abstract][Full Text] [Related]
2. Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice.
Li Y; Bader M; Tamargo I; Rubovitch V; Tweedie D; Pick CG; Greig NH
J Neurochem; 2015 Dec; 135(6):1203-1217. PubMed ID: 25982185
[TBL] [Abstract][Full Text] [Related]
3. Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson's disease.
Chen S; Yu SJ; Li Y; Lecca D; Glotfelty E; Kim HK; Choi HI; Hoffer BJ; Greig NH; Kim DS; Wang Y
Sci Rep; 2018 Jul; 8(1):10722. PubMed ID: 30013201
[TBL] [Abstract][Full Text] [Related]
4. Exendin-4 induced glucagon-like peptide-1 receptor activation reverses behavioral impairments of mild traumatic brain injury in mice.
Rachmany L; Tweedie D; Li Y; Rubovitch V; Holloway HW; Miller J; Hoffer BJ; Greig NH; Pick CG
Age (Dordr); 2013 Oct; 35(5):1621-36. PubMed ID: 22892942
[TBL] [Abstract][Full Text] [Related]
5. Neurotrophic and neuroprotective effects of a monomeric GLP-1/GIP/Gcg receptor triagonist in cellular and rodent models of mild traumatic brain injury.
Li Y; Glotfelty EJ; Namdar I; Tweedie D; Olson L; Hoffer BJ; DiMarchi RD; Pick CG; Greig NH
Exp Neurol; 2020 Feb; 324():113113. PubMed ID: 31730763
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide-1 receptor agonist Exendin-4 improves neurological outcomes by attenuating TBI- induced inflammatory responses and MAPK activation in rats.
Zhang J; Yi T; Cheng S; Zhang S
Int Immunopharmacol; 2020 Sep; 86():106715. PubMed ID: 32570036
[TBL] [Abstract][Full Text] [Related]
7. (-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer's disease challenged mice.
Lecca D; Bader M; Tweedie D; Hoffman AF; Jung YJ; Hsueh SC; Hoffer BJ; Becker RE; Pick CG; Lupica CR; Greig NH
Neurobiol Dis; 2019 Oct; 130():104528. PubMed ID: 31295555
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic properties and effects of PT302 after repeated oral glucose loading tests in a dose-escalating study.
Gu N; Cho SH; Kim J; Shin D; Seol E; Lee H; Lim KS; Shin SG; Jang IJ; Yu KS
Clin Ther; 2014 Jan; 36(1):101-14. PubMed ID: 24373998
[TBL] [Abstract][Full Text] [Related]
9. Novel GLP-1R/GIPR co-agonist "twincretin" is neuroprotective in cell and rodent models of mild traumatic brain injury.
Tamargo IA; Bader M; Li Y; Yu SJ; Wang Y; Talbot K; DiMarchi RD; Pick CG; Greig NH
Exp Neurol; 2017 Feb; 288():176-186. PubMed ID: 27845037
[TBL] [Abstract][Full Text] [Related]
10. Blast traumatic brain injury-induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4.
Tweedie D; Rachmany L; Rubovitch V; Li Y; Holloway HW; Lehrmann E; Zhang Y; Becker KG; Perez E; Hoffer BJ; Pick CG; Greig NH
Alzheimers Dement; 2016 Jan; 12(1):34-48. PubMed ID: 26327236
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective Effects and Treatment Potential of Incretin Mimetics in a Murine Model of Mild Traumatic Brain Injury.
Bader M; Li Y; Tweedie D; Shlobin NA; Bernstein A; Rubovitch V; Tovar-Y-Romo LB; DiMarchi RD; Hoffer BJ; Greig NH; Pick CG
Front Cell Dev Biol; 2019; 7():356. PubMed ID: 31998717
[TBL] [Abstract][Full Text] [Related]
12. Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice.
Tweedie D; Rachmany L; Rubovitch V; Lehrmann E; Zhang Y; Becker KG; Perez E; Miller J; Hoffer BJ; Greig NH; Pick CG
Exp Neurol; 2013 Jan; 239():170-82. PubMed ID: 23059457
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective exendin-4 enhances hypothermia therapy in a model of hypoxic-ischaemic encephalopathy.
Rocha-Ferreira E; Poupon L; Zelco A; Leverin AL; Nair S; Jonsdotter A; Carlsson Y; Thornton C; Hagberg H; Rahim AA
Brain; 2018 Oct; 141(10):2925-2942. PubMed ID: 30165597
[TBL] [Abstract][Full Text] [Related]
14. Glucose-Dependent Insulinotropic Polypeptide Ameliorates Mild Traumatic Brain Injury-Induced Cognitive and Sensorimotor Deficits and Neuroinflammation in Rats.
Yu YW; Hsieh TH; Chen KY; Wu JC; Hoffer BJ; Greig NH; Li Y; Lai JH; Chang CF; Lin JW; Chen YH; Yang LY; Chiang YH
J Neurotrauma; 2016 Nov; 33(22):2044-2054. PubMed ID: 26972789
[TBL] [Abstract][Full Text] [Related]
15. Cognitive Impairments Induced by Concussive Mild Traumatic Brain Injury in Mouse Are Ameliorated by Treatment with Phenserine via Multiple Non-Cholinergic and Cholinergic Mechanisms.
Tweedie D; Fukui K; Li Y; Yu QS; Barak S; Tamargo IA; Rubovitch V; Holloway HW; Lehrmann E; Wood WH; Zhang Y; Becker KG; Perez E; Van Praag H; Luo Y; Hoffer BJ; Becker RE; Pick CG; Greig NH
PLoS One; 2016; 11(6):e0156493. PubMed ID: 27254111
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of exenatide extended-release after single and multiple dosing.
Fineman M; Flanagan S; Taylor K; Aisporna M; Shen LZ; Mace KF; Walsh B; Diamant M; Cirincione B; Kothare P; Li WI; MacConell L
Clin Pharmacokinet; 2011 Jan; 50(1):65-74. PubMed ID: 21142268
[TBL] [Abstract][Full Text] [Related]
17. Exenatide Reverts the High-Fat-Diet-Induced Impairment of BDNF Signaling and Inflammatory Response in an Animal Model of Alzheimer's Disease.
Bomba M; Granzotto A; Castelli V; Onofrj M; Lattanzio R; Cimini A; Sensi SL
J Alzheimers Dis; 2019; 70(3):793-810. PubMed ID: 31256135
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin-Mimetic-Peptides Protect Cognitive Function after Mild Traumatic Brain Injury (mTBI).
Baratz-Goldstein R; Deselms H; Heim LR; Khomski L; Hoffer BJ; Atlas D; Pick CG
PLoS One; 2016; 11(6):e0157064. PubMed ID: 27285176
[TBL] [Abstract][Full Text] [Related]
19. Astaxanthin improves cognitive performance in mice following mild traumatic brain injury.
Ji X; Peng D; Zhang Y; Zhang J; Wang Y; Gao Y; Lu N; Tang P
Brain Res; 2017 Mar; 1659():88-95. PubMed ID: 28048972
[TBL] [Abstract][Full Text] [Related]
20. Corrigendum to "Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury" [Neurobiology of Disease Volume 124 (2019) 439-453 /YNBDI_4338].
Bader M; Li Y; Lecca D; Rubovitch V; Tweedie D; Glotfelty E; Rachmany L; Kim HK; Choi HI; Hoffer BJ; Pick CG; Greig NH; Kim DS
Neurobiol Dis; 2024 Jun; ():106563. PubMed ID: 38890024
[No Abstract] [Full Text] [Related]
[Next] [New Search]
